Breakthrough CAR-T Immunotherapy Eliminates Glioblastoma
Summary: Chimeric Antigen Receptor T-cell (CAR-T) therapy, which reprograms a patient’s own immune cells to attack cancer, has transformed treatment for blood cancers. Reproducing that success in aggressive brain tumours like glioblastoma has been challenging because the brain tumour microenvironment actively suppresses immune responses. New preclinical research shows that treating glioblastoma as a connected tumour–immune … Read more